Skip to main content

Month: March 2025

IDEX Biometrics ASA – Key information relating to possible subsequent offering/repair offering

Oslo, 11 March 2025 Reference is made to the stock exchange notice from IDEX Biometrics ASA (“IDEX” or the “Company”) on 11 March 2025 regarding irrevocable undertakings from certain existing shareholders for a total loan amount of NOK 30 million (“Loans”), and a possible subsequent offering, raising up to NOK 6 million, at the same subscription price as in the debt conversion related to the Loans (the “Subsequent Offering”), subject to approval by an Extraordinary General Meeting to be held on or about 11 April 2025. Date on which the terms and conditions of the subsequent offering/repair offering were announced: 11 March 2025; Last day including right: 10 March 2025; Ex-date: 11 March 2025; Record date: 12 March 2025; Date of approval: Expected to be on or about 11 April 2025 by resolution of an Extraordinary...

Continue reading

IDEX Biometrics ASA: Loan financing of NOK 30 million secured; proposed debt conversion; amendment of Convertible Bond

Oslo, 11 March 2025 NOTE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. LOAN FINANCING SECURED AND PROPOSED DEBT CONVERSIONIDEX Biometrics ASA (“IDEX” or the “Company”) announces that the Company has received irrevocable undertakings from certain existing shareholders and new investors (“Lenders”) for a total loan amount of NOK 30 million (“Loans”), which Loans shall be disbursed to IDEX in one or more instalments on such date(s) as determined by IDEX’s board of directors (“Board”) in its sole discretion. The net proceeds from the...

Continue reading

IDEX BIOMETRICS ASA REVISES ITS BUSINESS STRATEGY PLAN AND MAKES CHANGES IN MANAGEMENT

Oslo, Norway, 11 March 2025 Following the lack of revenues and low number of revenue-generating agreements secured in Q4 2024, the board of directors (“Board”) of IDEX Biometrics ASA (“IDEX”) has undertaken a strategic review, following which the Board has concluded on a new strategy, with a fundamental shift in how IDEX will take its technology and products to market. The review has concluded that IDEX has unique competitive advantages in its biometric Access technology (IDEX Access) and is optimally positioned to offer customers and new and existing channel partners a complete and ready to go product line. Government security agencies worldwide recommend everybody to upgrade their physical and digital security. It is believed that no other company can deliver an access product with IDEX’s level of security without compromising...

Continue reading

Kuros Biosciences grows sales to CHF 75.6 million for 2024

Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences grows sales to CHF 75.6 million for 2024 Financial HighlightsDirect MagnetOs™ sales increased by 136% to CHF 74.8 million (2023: CHF 31.7 million) Total Medical Device sales rose by 125% to CHF 75.6 million (2023: CHF 33.6 million) Total Group EBITDA reached CHF 2.2 million (2023: EBITDA loss of CHF (5.9) million), including the impairment, the group ended in a net loss of CHF (4.3) million Total Group adjusted EBITDA amounted to CHF 9.0 million, equaling a margin of 11.9% The Group surpassed the cash flow breakeven point on an annualized basis Cash and cash equivalents totaled CHF 18.0 million, up from CHF 14.2 million as of December 31, 2023 In 2025 Kuros will change its reporting currency from CHF to USD The Group expects sales growth of at...

Continue reading

Retail banks face a loyalty crunch as card experience leaves customers underwhelmed

Press contact:Fahd PashaTel.: + 1 647 860 3777E-mail: Fahd.Pasha@capgemini.com Retail banks face a loyalty crunch as card experience leaves customers underwhelmedOnly 26% of customers are satisfied with their cards experience Nearly one-in-two prospective customers abandon onboarding due to a poor experience 86% of executives plan to prioritize omnichannel experiences over the next 12 months to improve customer experience and build loyaltyParis, March 11, 2025 – The Capgemini Research Institute’s World Retail Banking Report 2025, published today, reveals a critical shortcoming in how retail banks appeal to the demands of digital-native, urban clients between the ages of 18-45. According to the report, while 73% of these credit card customers are motivated primarily by access to exclusive experiences, rewards and cashback offers,...

Continue reading

Magic Software and Matrix I.T sign MOU to Consider Merger

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Or Yehuda, Israel, March 10, 2025 (GLOBE NEWSWIRE) — Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC), a global provider of IT consulting services and end-to-end integration and application development platforms solutions, announced today that it signed an Memorandum of Understanding (“MOU“) with respect to a proposed merger with Matrix I.T Ltd. (TASE: MTRX). Magic is pleased to announce that on March 10, 2025, it entered into an MOU with Matrix I.T Ltd., a leading public Israeli IT services company whose shares are traded on the Tel Aviv Stock Exchange Ltd. (“Matrix“ and together with Magic, the “Companies“). According to the provisions of the MOU, Magic and Matrix agreed to...

Continue reading

Prospect Capital Corporation Releases Updated Prospect Highlights

NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) — Prospect Capital Corporation (NASDAQ: PSEC) (“Prospect”, “our”, or “we”) announced an updated “Prospect Highlights” has been posted to Prospect’s website. The updated Prospect Highlights is available here. The investor relations section of Prospect’s website (with Prospect Highlights, Corporate Presentation, and Press Releases) is available here. Prospect is proud to highlight our multi-decade history, strong track record, and market-leading best practices. About Prospect Capital CorporationProspect is a business development company lending to and investing in private businesses. Prospect’s investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. Prospect has elected to be treated as a business development company...

Continue reading

Meritage Announces the Passing of Board Member Duane Kluting

GRAND RAPIDS, Mich., March 10, 2025 (GLOBE NEWSWIRE) — Meritage Hospitality Group Inc. (OTCQX: MHGU), one of the nation’s premier franchise restaurant operators, today announced the sudden passing of Duane Kluting, a valued member of the Company’s Board of Directors. “It is with great sadness that I announce the passing of our friend and Board member, Duane Kluting. We are deeply grateful to Duane for his friendship, leadership and commitment to growing our business. Duane joined us in 2005 and has been a trustworthy contributor through the years. He was a valued member of our Audit Committee where he diligently served the company, bringing years of financial expertise from his career at BDO, Herman Miller and X-Rite. He contributed immeasurable value to our company’s board and will be greatly missed,” said Mr. Robert Schermer,...

Continue reading

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

STOUGHTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have two poster presentations highlighting real-world data from its differentiated neuropsychiatry product, Jornay PM, (methylphenidate HCl), a central nervous system (CNS) stimulant for the treatment of attention deficit hyperactivity disorder (ADHD) at the National Association of Pediatric Nurse Practitioners (NAPNAP) 46th National Conference on Pediatric Health Care, being held in Chicago, IL, from March 10-13, 2025. “Collegium is pleased to present real-world data at NAPNAP as part of our commitment to providing differentiated medicines that help to improve the lives of people living with serious medical conditions. The data being presented demonstrates the real-world benefit of Jornay PM as an important...

Continue reading

ArcelorMittal announces the publication of its 2024 annual report

10 March 2025, 23.55 CET ArcelorMittal has published its annual report for the year ended 31 December 2024. The report has been filed with the electronic database of the Luxembourg Stock Exchange (www.bourse.lu) and is available at http://corporate.arcelormittal.com > Financial reports ENDS About ArcelorMittal  ArcelorMittal is one of the world’s leading integrated steel and mining companies with a presence in 60 countries and primary steelmaking operations in 15 countries. It is the largest steel producer in Europe, among the largest in the Americas, and has a growing presence in Asia through its joint venture AM/NS India. ArcelorMittal sells its products to a diverse range of customers including the automotive, engineering, construction and machinery industries, and in 2024 generated revenues of $62.4 billion, produced 57.9 million metric...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.